Oncology

Oncology

A targeted approach to developing targeted blood cancer therapiesA targeted approach to developing targeted blood cancer therapies
A targeted approach to developing targeted blood cancer therapies

Precision medicine and targetted solutions can be utilised to treat cancer, but how can this develop in the future?

May 31, 2022 Oncology
Supporting the challenges of innovative systemic treatmentsSupporting the challenges of innovative systemic treatments
Supporting the challenges of innovative systemic treatments

How can the benefits of immunotherapy be maximised for each patient?

May 31, 2022 Oncology
NHS waiting lists: the second healthcare crisis?NHS waiting lists: the second healthcare crisis?
NHS waiting lists: the second healthcare crisis?

Novartis UK tells Pharmafile how COVID-19 impacted patient access to oncology treatments, and how the pharma industry can support the NHS

May 31, 2022 Oncology
Embrace disruption: the changing landscape of clinical researchEmbrace disruption: the changing landscape of clinical research
Embrace disruption: the changing landscape of clinical research

How can precision medicine and personalised treatments improve healthcare in Europe and worldwide?

May 31, 2022 Oncology
New treatments and new challenges: The oncology constant is changeNew treatments and new challenges: The oncology constant is change
New treatments and new challenges: The oncology constant is change

The UK has seen many innovations in the healthcare sphere, many have which have been in oncology, but what are the next steps in this ever-evolving field?

May 31, 2022 Oncology
Novel targets are the future of solid tumour immunotherapyNovel targets are the future of solid tumour immunotherapy
Novel targets are the future of solid tumour immunotherapy

Pharmafile speaks to Enara Bio: Enara Bio tell Pharmafile about the unmet patient needs in oncology, and how these can be tackled by novel therapies, as well as considering the future of immunotherapy

May 31, 2022 Oncology